Author:
Saxena Ruchi,Chandra Vishal,Manohar Murli,Hajela Kanchan,Debnath Utsab,Prabhakar Yenamandra S.,Saini Karan Singh,Konwar Rituraj,Kumar Sandeep,Megu Kaling,Roy Bal Gangadhar,Dwivedi Anila
Publisher
Public Library of Science (PLoS)
Reference38 articles.
1. ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective;R Saxena;Med Res Rev,2012
2. Jordan VC (1992) The strategic use of antiestrogens to control the development and growth of breast cancer. Cancer 70 (4 Suppl): :977–982.
3. The hallmarks of cancer;D Hanahan;Cell,2000
4. How to target estrogen receptor-negative breast cancer?;H Rochefort;Endocr Relat Cancer,2003
5. Understanding and treating triple-negative breast cancer;C Anders;Oncology (Williston Park),2008
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献